|
- JAN 19
- Masamitsu Tanaka (Growth Factor Division)
Involvement of Eph receptor tyrosine kinase and ephrin ligand in the regulation of cell-to-cell adhesion by interaction with claudins
- Tsutomu Ohta (Center for Medical Genomics)
Functional analysis of SYT-SSX1 fusion gene in synovial sarcomas
- FEB 16
- Kazunori Aoki (Section for Studies on Host-Immune Response)
Development of interferon gene therapy using liver fibrosis and pancreatic cancer models
Shin'ichi Miyamoto (Pathology Division, East)
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein-3
- APR 19
- Hiroyuki Tsuda (Chemotherapy Division/Nagoya City University)
Histogenetic analysis of mammary and pancreas tumors in rats carrying mutated human c-Ha-ras transgene
Yoshiko Takahashi (Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening/Independent Administrative Institution The National Institute of Health and Nutrition)
A population-based dietary intervention trial in a high-risk area for stomach cancer: development and evaluation
- MAY 17
- Kazufumi Honda (Chemotherapy Division and Cancer Proteomics Project)
Expression of actinin-4 enhances cell motility and mediates the lymphatic spread of colorectal cancer
Yukari Totsuka (Cancer Prevention Basic Research Project)
Biological activities of aminophenylnorharman (APNH) formed from norharman with aniline
- JUL 26
- Masanobu Abe (Carcinogenesis Division)
"Methylation pressure" specific to neuroblastomas with poor prognosis
Masachika Tani (Biology Division)
Biological significance of MYO18B alterations in lung cancer cells
- SEP 13
- Yasutoshi Tatsumi (Virology Division)
Unregulated expression of human Cdt1 leads to chromosomal damage and ATM checkpoint activation
Takumi Teratani (Section for Studies on Metastasis)
Establishment of rat ES cells and application for cancer research
- OCT 18
- Mami Takahashi (Cancer Prevention Basic Research Project)
Suppressive effects of PGE2 receptor antagonists and PPAR agonists on colon carcinogenesis
Chisato Hamashima (Statistics and Cancer Control Division, Research Center for Cancer Prevention and Screening)
Evaluation of cancer screening
- NOV 15
- Masashi Idogawa (Chemotherapy Division)
Proteomic analysis of the TCF-4/b-catenin transcriptional complex
Shigeru Sasaki (Biology Division)
Investigation of molecular process of chromosome deletions based on the structural analysis of their breakpoints
|
|
